 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, March 9, 2005, 25(10):2463-2470; doi:10.1523/JNEUROSCI.4385-04.2005
Previous Article | Next Article
Neurobiology of Disease
Mutant Superoxide Dismutase 1 Forms Aggregates in the Brain Mitochondrial Matrix of Amyotrophic Lateral Sclerosis Mice
Chetan Vijayvergiya,1 M. Flint Beal,1 Jochen Buck,2 andGiovanni Manfredi1 Departments of 1Neurology and Neuroscience and 2Pharmacology, Weill Medical College of Cornell University, New York, New York 10021
An increasing body of evidence suggests that mitochondrial dysfunction plays an important role in the pathogenesis of familial amyotrophic lateral sclerosis associated with "gain of function" mutations in Cu/Zn superoxide dismutase 1 (SOD1). SOD1 is mostly a cytosolic protein, but a portion of SOD1 is localized in mitochondria of patients with familial amyotrophic lateral sclerosis and transgenic mouse models of the disease. Despite the finding that mutant SOD1 localizes in mitochondria, the pathogenic significance of the mitochondrial mutant SOD1 remains to be elucidated. Here, we demonstrate that both wild-type and mutant human SOD1 accumulate in brain mitochondria of transgenic mice and that SOD1 displays a very complex intramitochondrial compartmentalization. For the first time, we show that, in addition to being in the mitochondrial outer membrane and intermembrane space, SOD1 is also localized in the mitochondrial matrix. Importantly, we show that aberrant SOD1 macromolecular aggregates are formed in the matrix of brain mitochondria. This suggests that mutant SOD1 in the brain mitochondrial matrix is misfolded and prone to aggregation, which may contribute to selective neuronal degeneration.
Key words: ALS; amyotrophic lateral sclerosis; matrix; mitochondria; aggregation; SOD1; brain
Received Oct 21, 2004; revised January 18, 2005; accepted January 20, 2005.
This article has been cited by other articles:
H. Kawamata and G. Manfredi
Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria
Hum. Mol. Genet., November 1, 2008; 17(21): 3303 - 3317.
[Abstract] [Full Text] [PDF]
H. Kawamata, J. Magrane, C. Kunst, M. P. King, and G. Manfredi
Lysyl-tRNA Synthetase Is a Target for Mutant SOD1 Toxicity in Mitochondria
J. Biol. Chem., October 17, 2008; 283(42): 28321 - 28328.
[Abstract] [Full Text] [PDF]
M. Son, S. C. Leary, N. Romain, F. Pierrel, D. R. Winge, R. G. Haller, and J. L. Elliott
Isolated Cytochrome c Oxidase Deficiency in G93A SOD1 Mice Overexpressing CCS Protein
J. Biol. Chem., May 2, 2008; 283(18): 12267 - 12275.
[Abstract] [Full Text] [PDF]
P. Cassina, A. Cassina, M. Pehar, R. Castellanos, M. Gandelman, A. de Leon, K. M. Robinson, R. P. Mason, J. S. Beckman, L. Barbeito, et al.
Mitochondrial Dysfunction in SOD1G93A-Bearing Astrocytes Promotes Motor Neuron Degeneration: Prevention by Mitochondrial-Targeted Antioxidants
J. Neurosci., April 16, 2008; 28(16): 4115 - 4122.
[Abstract] [Full Text] [PDF]
C. Vande Velde, T. M. Miller, N. R. Cashman, and D. W. Cleveland
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria
PNAS, March 11, 2008; 105(10): 4022 - 4027.
[Abstract] [Full Text] [PDF]
M. Son, K. Puttaparthi, H. Kawamata, B. Rajendran, P. J. Boyer, G. Manfredi, and J. L. Elliott
Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology
PNAS, April 3, 2007; 104(14): 6072 - 6077.
[Abstract] [Full Text] [PDF]
A. Ferri, M. Cozzolino, C. Crosio, M. Nencini, A. Casciati, E. B. Gralla, G. Rotilio, J. S. Valentine, and M. T. Carri
Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials
PNAS, September 12, 2006; 103(37): 13860 - 13865.
[Abstract] [Full Text] [PDF]
K. Aquilano, P. Vigilanza, G. Rotilio, and M. R. Ciriolo
Mitochondrial damage due to SOD1 deficiency in SH-SY5Y neuroblastoma cells: a rationale for the redundancy of SOD1
FASEB J, August 1, 2006; 20(10): 1683 - 1685.
[Abstract] [Full Text] [PDF]
C. A. Wood-Allum, S. C. Barber, J. Kirby, P. Heath, H. Holden, R. Mead, A. Higginbottom, S. Allen, T. Beaujeux, S. E. Alexson, et al.
Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen
Brain, July 1, 2006; 129(7): 1693 - 1709.
[Abstract] [Full Text] [PDF]
H.-X. Deng, Y. Shi, Y. Furukawa, H. Zhai, R. Fu, E. Liu, G. H. Gorrie, M. S. Khan, W.-Y. Hung, E. H. Bigio, et al.
Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria
PNAS, May 2, 2006; 103(18): 7142 - 7147.
[Abstract] [Full Text] [PDF]
D. Bergemalm, P. A. Jonsson, K. S. Graffmo, P. M. Andersen, T. Brannstrom, A. Rehnmark, and S. L. Marklund
Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models.
J. Neurosci., April 19, 2006; 26(16): 4147 - 4154.
[Abstract] [Full Text] [PDF]
K. Yamanaka and D. W. Cleveland
Determinants of rapid disease progression in ALS
Neurology, December 27, 2005; 65(12): 1859 - 1860.
[Full Text] [PDF]
A. Tiwari, Z. Xu, and L. J. Hayward
Aberrantly Increased Hydrophobicity Shared by Mutants of Cu,Zn-Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis
J. Biol. Chem., August 19, 2005; 280(33): 29771 - 29779.
[Abstract] [Full Text] [PDF]
J. Wang, G. Xu, H. Li, V. Gonzales, D. Fromholt, C. Karch, N. G. Copeland, N. A. Jenkins, and D. R. Borchelt
Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: {alpha}B-crystallin modulates aggregation
Hum. Mol. Genet., August 15, 2005; 14(16): 2335 - 2347.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|